Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
Juanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
EBioMedicine (2021) Vol. 74, pp. 103748-103748
Open Access | Times Cited: 20

Showing 20 citing articles:

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
Jie Hu, Pai Peng, Xiaoxia Cao, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 293-295
Open Access | Times Cited: 208
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
David H. Canaday, Oladayo A. Oyebanji, Elizabeth M. White, et al.
EBioMedicine (2022) Vol. 80, pp. 104066-104066
Open Access | Times Cited: 46
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Anu Haveri, Anna Solastie, Nina Ekström, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 5, pp. 816-824
Open Access | Times Cited: 39
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
Dale Kitchin, Simone I. Richardson, Mieke A. van der Mescht, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100535-100535
Open Access | Times Cited: 35
PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
Viviana Simon, Vamsi Kota, Ryan F. Bloomquist, et al.
mSphere (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 30
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
K. H. Bjørlykke, Hilde S Ørbo, Anne Therese Tveter, et al.
The Lancet Rheumatology (2022) Vol. 5, Iss. 1, pp. e36-e46
Open Access | Times Cited: 20
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Vivian Glück, Leonid Tydykov, Anna-Lena Mader, et al.
Infection (2022) Vol. 50, Iss. 6, pp. 1475-1481
Open Access | Times Cited: 17
Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers
Oladayo A Oyebanji, Nicholas Sundheimer, Vaishnavi Ragavapuram, et al.
GeroScience (2024) Vol. 46, Iss. 6, pp. 6183-6194
Open Access | Times Cited: 2
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
Harvey W. Kaufman, William A. Meyer, Nigel J. Clarke, et al.
Population Health Management (2023) Vol. 26, Iss. 1, pp. 29-36
Open Access | Times Cited: 6
The changing health impact of vaccines in the COVID-19 pandemic: A modeling study
Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska‐Griffiths, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112308-112308
Open Access | Times Cited: 6
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rdmRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults
Anu Haveri, Anna Solastie, Nina Ekström, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
Jing Wang, Lei Huang, Nan Guo, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 917-917
Open Access | Times Cited: 3
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan
Tomoyuki Kakugawa, Keiko Doi, Yuichi Ohteru, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
Juan Hormazábal, Loreto Núñez, Paola Rubilar, et al.
Vaccine X (2023) Vol. 15, pp. 100372-100372
Open Access | Times Cited: 2
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: a systematic review
María Consuelo Bachmann, Nejla Gültekin, Zeno Stanga, et al.
New Microbes and New Infections (2024) Vol. 63, pp. 101551-101551
Open Access
The changing impact of vaccines in the COVID-19 pandemic
Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska‐Griffiths, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies
Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, et al.
(2023)
Open Access | Times Cited: 1
Reduced infectivity but increased immune escape of the new SARS-CoV-2 variant of concern Omicron
Jie Hu, Pai Peng, Kang Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: A prospective longitudinal study
Tomoyuki Kakugawa, Keiko Doi, Yuichi Ohteru, et al.
Research Square (Research Square) (2023)
Open Access
Antibody Affinity Maturation to SARS-CoV-2 Omicron Variants in a Teachers Cohort
Philip H. James-Pemberton, Shivali Kohli, Aaron C. Westlake, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top